secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K/A
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001493152-23-036768
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte completes engagement of Marcum LLP as independent auditor for FY2023
-----------------------------------------------------------------------------

- Marcum LLP completed client acceptance procedures on October 10, 2023, satisfying the condition noted in the original 8-K.
- Marcum provided a fully executed engagement letter, formalizing its appointment as auditor for FY2023.
- No other changes from the previously reported auditor change; this amendment solely confirms the completion of the engagement process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223036768/0001493152-23-036768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223036768/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-036768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer